Showing results (111-120 of 630) with videos related to

Sort By:
Pageof 63
Vox Sanguinis|November 5, 1999
Use of recombinant, activated factor VII in the treatment of congenital factor VII deficienciesG Mariani, M G Testa, T Di Paolantonio, et al.
Bone Marrow Transplantation|March 29, 2002
Acquired factor VII deficiency in hematopoietic stem cell transplant recipientsA A Toor, A Slungaard, U Hedner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 16, 1999
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0E Erhardtsen, P Nony, M Dechavanne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic proceduresH A Cooper, C P Jones, E Campion, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand diseaseK M Brinkhous, U Hedner, J B Garris, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1987
On the unreliability of one-stage factor VIII:C clotting assays after infusion of factor VIII concentratesM Blombäck, H Kjellman, J P Allain, et al.
Thrombosis Research|July 19, 2000
Correlation between different intensities of anti-vitamin K treatment and coagulation parametersA Jerkeman, J Astermark, U Hedner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
The effect of recombinant aprotinin on t-PA-induced bleeding in ratsE Erhardtsen, C Bregengaard, U Hedner, et al.
World Journal of Surgery|January 1, 1977
Surgery of hemophiliacs--20 years' experienceI M Nilsson, U Hedner, A Ahlberg, et al.
Pageof 63